Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19

J Neuroophthalmol. 2020 Sep;40(3):398-402. doi: 10.1097/WNO.0000000000001049.

Authors

Siwei Zhou¹, Edward C Jones-Lopez, Deepak J Soneji, Christina J Azevedo, Vivek R Patel

Affiliation

¹ Division of Neuro-Ophthalmology (SZ, VRP), USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; Division of Infectious Disease (ECJ-L), Department of Internal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; and Division of Neuroimmunology (DJS, CJA), Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Autoantibodies / blood*
Betacoronavirus*
COVID-19
Coronavirus Infections / immunology*
Glucocorticoids / therapeutic use
Humans
Magnetic Resonance Imaging
Male
Methylprednisolone / therapeutic use
Myelin-Oligodendrocyte Glycoprotein / immunology*
Myelitis / diagnostic imaging
Myelitis / drug therapy
Myelitis / immunology*
Optic Neuritis / diagnostic imaging
Optic Neuritis / drug therapy
Optic Neuritis / immunology*
Pandemics
Pneumonia, Viral / immunology*
Prednisone / therapeutic use
Real-Time Polymerase Chain Reaction
SARS-CoV-2

Substances

Autoantibodies
Glucocorticoids
Myelin-Oligodendrocyte Glycoprotein
Prednisone
Methylprednisolone